Evidence map›Paper›PMID 34829099›Full record

ArticleFoods (Basel, Switzerland)2021

Characterization of a Novel L-Asparaginase from

Huibing Chi, Meirong Chen, Linshu Jiao, Zhaoxin Lu, Xiaomei Bie, Haizhen Zhao, Fengxia Lu

Open access · goldAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Hyperthermophilic L-Asparaginase fromInternational journal of molecular sciences · 2025
    Article
  3. Review
  4. Characterization ofACS omega · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Characterization of L-asparaginase from Streptomyces koyangensis SK4 with acrylamide-minimizing potential in potato chips.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Enhancing the Catalytic Activity of Type II L-Asparaginase fromInternational journal of molecular sciences · 2022
    Article
  13. Cis-Element Engineering Promotes the Expression ofInternational journal of molecular sciences · 2022
    Article
  14. The Acrylamide Degradation by Probiotic StrainFoods (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Huibing ChiCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.
Meirong ChenCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.
Linshu JiaoCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.
Zhaoxin LuCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.ORCID 0000-0001-9288-7419
Xiaomei BieCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.
Haizhen ZhaoCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.
Fengxia LuCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.
Nanjing Agricultural University · CN

Funding

National Natural Science Foundation of China 31871742
6 · The paper itself

Abstract

L-asparaginase (E.C.3.5.1.1) is a well-known agent that prevents the formation of acrylamide both in the food industry and against childhood acute lymphoblastic leukemia in clinical settings. The disadvantages of L-asparaginase, which restrict its industrial application, include its narrow range of pH stability and low thermostability. In this study, a novel L-asparaginase from

Indexed as

acrylamideL-asparaginaseMycobacterium gordonaethermal stability

Identifiers

PMID34829099
PMCPMC8617759
OpenAlexW3212326859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.